Warning: is_readable(): open_basedir restriction in effect. File(/home/uterine/.SGCache/cache_status) is not within the allowed path(s): (/var/www/vhosts/uterine-fibroids.org/:/tmp/) in /var/www/vhosts/uterine-fibroids.org/httpdocs/wp-content/plugins/sg-cachepress/core/Memcache/Memcache.php on line 138

Warning: is_readable(): open_basedir restriction in effect. File(/home/uterine/.SGCache/cache_status) is not within the allowed path(s): (/var/www/vhosts/uterine-fibroids.org/:/tmp/) in /var/www/vhosts/uterine-fibroids.org/httpdocs/wp-content/plugins/sg-cachepress/core/Memcache/Memcache.php on line 138

Notice: A session had already been started - ignoring session_start() in /var/www/vhosts/uterine-fibroids.org/httpdocs/wp-content/themes/insightec/functions.php on line 424
FDA OKS CHANGES FOR INSIGHTEC'S EXABLATE - non-invasive essential tremor treatment

Notizie

FDA OKS CHANGES FOR INSIGHTEC’S EXABLATE

23
aprile

MR-guided focused ultrasound (MRgFUS) developer INSIGHTEC has received U.S. Food and Drug Administration (FDA) clearance for a new version of its Exablate device and a change in labelling.

The new version of system is cleared for the treatment of symptomatic uterine fibroids, and with the updated labelling, fibroid tissue ablation can now be considered for patients who wish to retain fertility, the company said. Link to full article.

More Articles

Notizie
Notizie

INSIGHTEC’S EXABLATE SYSTEM SPARES THE UTERUS WHEN TREATING UTERINE FIBROIDS

Notizie
Notizie

MRgFUS FEATURED ON RADIOLOGY TODAY ‘S COVER

Font Resize